- Investing Ideas
- /
- Telecom Healthcare Sector
Telecom Healthcare Sector
Results
2306
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2306 companies
Kelyniam Global
Market Cap: US$7.8m
A medical device manufacturing company, engages in the production of custom prosthetics cranial implants utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers in the United States.
KLYG
US$0.15
7D
-13.9%
1Y
158.3%
Sensei Biotherapeutics
Market Cap: US$7.8m
A clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients.
SNSE
US$0.32
7D
-5.8%
1Y
-76.5%
StimCell Energetics
Market Cap: US$7.8m
A biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States.
STME
US$0.39
7D
-0.7%
1Y
11.3%
Turnstone Biologics
Market Cap: US$7.7m
Operates as a biotechnology company.
TSBX
US$0.34
7D
-2.3%
1Y
-86.8%
Carisma Therapeutics
Market Cap: US$7.7m
A biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States.
CARM
US$0.18
7D
-8.8%
1Y
-87.5%
Silexion Therapeutics
Market Cap: US$7.6m
A biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors.
SLXN
US$0.92
7D
-4.1%
1Y
-99.1%
MetaVia
Market Cap: US$7.6m
A clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases.
MTVA
US$0.81
7D
19.8%
1Y
-79.6%
Tissue Repair
Market Cap: AU$11.8m
A clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia.
TRP
AU$0.20
7D
2.6%
1Y
-11.4%
Revive Therapeutics
Market Cap: CA$10.5m
A life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders.
RVV
CA$0.025
7D
0%
1Y
0%
Ainos
Market Cap: US$7.5m
A healthcare company, focuses on the development of novel point-of-care testing therapeutics based on very low-dose interferon alpha and synthetic RNA-driven preventative medicine.
AIMD
US$0.48
7D
-11.4%
1Y
-61.8%
Lipella Pharmaceuticals
Market Cap: US$7.5m
A clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications.
LIPO
US$2.99
7D
34.1%
1Y
-42.9%
Apollomics
Market Cap: US$7.5m
A clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer.
APLM
US$7.26
7D
57.0%
1Y
-72.6%
BioVaxys Technology
Market Cap: CA$10.3m
A clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms and immuno-diagnostics.
BIOV
CA$0.04
7D
14.3%
1Y
-42.9%
Crescita Therapeutics
Market Cap: CA$10.3m
A dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally.
CTX
CA$0.54
7D
3.8%
1Y
14.9%
WORK Medical Technology Group
Market Cap: US$7.4m
Manufactures and sells medical consumables in the People’s Republic of China and internationally.
WOK
US$0.70
7D
25.7%
1Y
n/a
Univec
Market Cap: US$7.3m
Provides health care services in the United States.
UNVC
US$0.0026
7D
2.0%
1Y
-46.9%
China Pharma Holdings
Market Cap: US$7.3m
Develops, manufactures, and markets pharmaceutical products for human use in the People’s Republic of China.
CPHI
US$2.21
7D
-6.0%
1Y
-25.1%
Nextleaf Solutions
Market Cap: CA$10.0m
A cannabis extraction technology company, engages in the manufacture and distribution of cannabinoid vapes, oils, and softgels in Canada.
OILS
CA$0.06
7D
20.0%
1Y
-57.1%
Cytophage Technologies
Market Cap: CA$10.0m
A biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada.
CYTO
CA$0.18
7D
-32.7%
1Y
-63.7%
Christina Lake Cannabis
Market Cap: CA$9.9m
Engages in the research and development, cultivation, processing, production, and sale license of cannabis in British Columbia, Canada.
CLC
CA$0.045
7D
-10.0%
1Y
50.0%
PharmaCyte Biotech
Market Cap: US$7.1m
A biotechnology company, develops and commercializes cellular therapies for cancer in the United States.
PMCB
US$1.04
7D
-0.3%
1Y
-51.1%
Healixa
Market Cap: US$7.1m
Operates as a technology company with assets in both healthtech and fintech.
EMOR
US$0.013
7D
13.4%
1Y
-86.7%
Veltex
Market Cap: US$7.1m
Focuses on the development and acquisition of companies that have modalities in the areas of health, wellness, and recovery.
VLXC
US$0.07
7D
0%
1Y
-53.3%
Mainz Biomed
Market Cap: US$7.1m
Develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe.
MYNZ
US$2.09
7D
-7.7%
1Y
-91.1%
Medicure
Market Cap: CA$9.8m
A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.
MPH
CA$0.94
7D
-6.0%
1Y
-10.5%
ProText Mobility
Market Cap: US$7.0m
A biotech company, engages in the development of pharmaceutical botanical medicines.
TXTM
US$0.0007
7D
0%
1Y
-36.4%
Citius Pharmaceuticals
Market Cap: US$7.0m
A biopharmaceutical company, focuses on the development and commercialization of critical care products.
CTXR
US$0.72
7D
-12.5%
1Y
-95.8%
Percheron Therapeutics
Market Cap: AU$10.9m
Engages in the research and development of novel antisense pharmaceuticals in Australia.
PER
AU$0.01
7D
0%
1Y
-86.3%
Impact BioMedical
Market Cap: US$6.9m
Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States.
IBO
US$0.55
7D
7.0%
1Y
n/a
Telo Genomics
Market Cap: CA$9.5m
A molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions primarily in Canada.
TELO
CA$0.09
7D
0%
1Y
-51.4%
Innovotech
Market Cap: CA$9.4m
Provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally.
IOT
CA$0.20
7D
5.3%
1Y
n/a
PharmaCielo
Market Cap: CA$9.4m
Together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada.
PCLO
CA$0.05
7D
0%
1Y
n/a
Cardiogeni
Market Cap: UK£5.0m
A clinical stage biotechnology company, develops heart failure medicines.
CGNI
UK£0.06
7D
0%
1Y
n/a
Atomo Diagnostics
Market Cap: AU$10.5m
Engages in the development and sale of medical devices worldwide.
AT1
AU$0.017
7D
-2.9%
1Y
-46.8%
Xylo Technologies
Market Cap: US$6.7m
A technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally.
XYLO
US$5.15
7D
-3.7%
1Y
-9.4%
Glow Lifetech
Market Cap: CA$9.4m
A biotechnology company, focuses on producing nutraceutical and cannabinoid-based products.
GLOW
CA$0.055
7D
0%
1Y
n/a